Glenn R. Mattes - 16 Sep 2021 Form 4 Insider Report for TFF Pharmaceuticals, Inc.

Role
President and CEO, Director
Signature
/s/ Glenn R. Mattes, by Kirk Allen Coleman, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Sep 2021
Net transactions value
+$71,000
Form type
4
Filing time
16 Sep 2021, 13:35:40 UTC
Next filing
17 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TFFP Common Stock Purchase $71,000 +10,000 +100% $7.10* 20,000 16 Sep 2021 Direct
holding TFFP Common Stock 7,000 16 Sep 2021 Shares held by spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.